The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...

An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. The vaccine would allow babies to be born ...

This is a carousel. Use Next and Previous buttons to navigate WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with ...

Two new vaccines for respiratory syncytial virus (RSV) are available this year for people aged 60 and older, as well as for ...

The latest COVID-19 boosters could be approved and on their way to health systems this week. The question: Will people go and ...

A panel of advisers recommended the Centers for Disease Control and Prevention add Pfizer Inc.’s RSV vaccine to the list of shots for pregnant people to protect infants ...

US regulators approved updated versions of the COVID-19 vaccines made by Pfizer Inc. and Moderna Inc. Monday as ...

US FDA Approves Pfizer's Maternal RSV Vaccine to Protect Infants By Patrick Wingrove and Bhanvi Satija (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory ...

The U.S. Food and Drug Administration on Monday approved new COVID boosters for Americans, setting the stage for the updated ...

The US Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their ...

The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...